Document is current
Any future updates will be listed below
-
Authors
Nachmanson, Daniela
Pagadala, Meghana
Steward, Joseph
Cheung, Callie
Bruce, Lauryn Keeler
Lee, Nicole Q.
O’Keefe, Thomas J.
Lin, Grace Y.
Hasteh, Farnaz
Morris, Gerald P.
Carter, Hannah
Harismendy, Olivier https://orcid.org/0000-0002-8098-9888
-
Funding
Funding for this research was provided by:
Center for Scientific Review (U01CA196406, U01CA196383, T32GM008806, T15LM011271, U54CA209891, P30CA023100)
Mark Foundation For Cancer Research (#18-022-ELA)
Tobacco-Related Disease Research Program (28DT-0011)
- License Information
-
More Information
Article History
Received: 3 September 2022
Accepted: 5 December 2022
First Online: 27 December 2022
Declarations
:
: The lung cancer patients were consented to the UC San Diego Biorepository and Tissue Technology Shared Resource, as a biorepository approved by the UC San Diego Institutional Review Board (protocols 090401 and 181755). The breast precancer patients were included in the ATHENA DCIS registry, a retrospective study approved by the UC San Diego Institutional Review Board (protocol 171481), which provided a waiver of consent.
: Not applicable.
: O.H. is an employee of Zentalis Pharmaceuticals. D.N. is an employee of TwinStrand Inc. The other authors declare no potential conflicts of interest.
